Constitutive Phosphoinositide 3-Kinase Activation in Acute Myeloid Leukemia Is Not Due to P110δ Mutations

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phosphoinositide 3-Kinase-Δ (PI3Kδ); Phosphoinositide 3-Kinase Catalytic Subunit Δ-Polypeptide (PI3KCD; P110δ)

Science-Business eXchange
2014English

Constitutive Activation of SHP2 in Mice Cooperates With ICSBP Deficiency to Accelerate Progression to Acute Myeloid Leukemia

Journal of Clinical Investigation
Medicine
2008English

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Landscape of TET2 Mutations in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Acute Myeloid Leukemia With NPM1 Somatic Mutations

2020English

Current Findings for Recurring Mutations in Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2011English

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts

Transplantation
Transplantation
2012English

Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase B

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy